PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery

Numerous human disorders can benefit from targeted, intravenous (IV) drug delivery. Polymeric nanoparticles have been designed to undergo systemic circulation and deliver their therapeutic cargo to target sites in a controlled manner. Poly(lactic‐co‐glycolic) acid (PLGA) is a particularly promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheffey, Violet V., Siew, Emily B., Tanner, Eden E. L., Eniola‐Adefeso, Omolola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035064/
https://www.ncbi.nlm.nih.gov/pubmed/35032406
http://dx.doi.org/10.1002/adhm.202101536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035064/
https://www.ncbi.nlm.nih.gov/pubmed/35032406
http://dx.doi.org/10.1002/adhm.202101536

Ejemplares similares